NU 641 Advanced Clinical Pharmacology Exam 1 Questions and
Answers and Explanations | Latest - Regis
1. Which phase of pharmacokinetics is primarily affected by a patient’s liver
function?
A. Absorption
B. Metabolism
C. Distribution
D. Excretion
Answer: B
Explanation: Metabolism, or biotransformation, occurs primarily in the liver via enzymes
like the Cytochrome P450 system.
2. A drug with a high therapeutic index is considered:
A. Extremely potent
B. Highly toxic
C. Relatively safe
D. Slowly absorbed
Answer: C
Explanation: The therapeutic index is the ratio of the toxic dose to the therapeutic dose; a
high index indicates a wide margin of safety.
,3. How many half-lives does it typically take for a drug to reach steady-state
concentration in the blood?
A. 4 to 5
B. 2 to 3
C. 1 to 2
D. 8 to 10
Answer: A
Explanation: It generally takes approximately 4 to 5 half-lives for a drug’s intake to equal
its elimination, achieving steady state.
4. Which of the following is an example of a Phase II metabolic reaction?
A. Oxidation
B. Glucuronidation
C. Hydrolysis
D. Reduction
Answer: B
Explanation: Phase II reactions involve conjugation, such as glucuronidation, which makes
the drug more polar and water-soluble for excretion.
5. An agonist is a drug that:
A. Binds to a receptor and activates it
B. Blocks a receptor site
,C. Prevents other drugs from binding
D. Degrades neurotransmitters
Answer: A
Explanation: Agonists mimic the action of endogenous ligands by binding to and activating
receptors to produce a biological response.
6. The ‘first-pass effect’ refers to:
A. Metabolism of a drug in the liver before reaching systemic circulation
B. Binding of drugs to plasma proteins
C. Excretion through the kidneys
D. The time it takes for a drug to reach the brain
Answer: A
Explanation: Oral drugs are absorbed in the GI tract and carried to the liver via the portal
vein, where they may be significantly metabolized before entering the bloodstream.
7. Which protein is the most important for drug binding in the plasma?
A. Hemoglobin
B. Albumin
C. Gamma globulin
D. Transferrin
Answer: B
, Explanation: Albumin is the primary protein to which drugs bind; low albumin levels can
lead to increased levels of free (active) drug.
8. Which route of administration provides 100% bioavailability?
A. Intravenous
B. Intramuscular
C. Oral
D. Transdermal
Answer: A
Explanation: Intravenous administration bypasses absorption barriers and the first-pass
effect, delivering the entire dose directly into systemic circulation.
9. A patient with chronic renal failure would likely require:
A. Lower doses or longer intervals of renal-excreted drugs
B. Higher doses of renal-excreted drugs
C. Frequent administration of prodrugs
D. No change in medication dosing
Answer: A
Explanation: Decreased renal clearance means drugs stay in the body longer, necessitating
dose reductions or increased dosing intervals to avoid toxicity.
Answers and Explanations | Latest - Regis
1. Which phase of pharmacokinetics is primarily affected by a patient’s liver
function?
A. Absorption
B. Metabolism
C. Distribution
D. Excretion
Answer: B
Explanation: Metabolism, or biotransformation, occurs primarily in the liver via enzymes
like the Cytochrome P450 system.
2. A drug with a high therapeutic index is considered:
A. Extremely potent
B. Highly toxic
C. Relatively safe
D. Slowly absorbed
Answer: C
Explanation: The therapeutic index is the ratio of the toxic dose to the therapeutic dose; a
high index indicates a wide margin of safety.
,3. How many half-lives does it typically take for a drug to reach steady-state
concentration in the blood?
A. 4 to 5
B. 2 to 3
C. 1 to 2
D. 8 to 10
Answer: A
Explanation: It generally takes approximately 4 to 5 half-lives for a drug’s intake to equal
its elimination, achieving steady state.
4. Which of the following is an example of a Phase II metabolic reaction?
A. Oxidation
B. Glucuronidation
C. Hydrolysis
D. Reduction
Answer: B
Explanation: Phase II reactions involve conjugation, such as glucuronidation, which makes
the drug more polar and water-soluble for excretion.
5. An agonist is a drug that:
A. Binds to a receptor and activates it
B. Blocks a receptor site
,C. Prevents other drugs from binding
D. Degrades neurotransmitters
Answer: A
Explanation: Agonists mimic the action of endogenous ligands by binding to and activating
receptors to produce a biological response.
6. The ‘first-pass effect’ refers to:
A. Metabolism of a drug in the liver before reaching systemic circulation
B. Binding of drugs to plasma proteins
C. Excretion through the kidneys
D. The time it takes for a drug to reach the brain
Answer: A
Explanation: Oral drugs are absorbed in the GI tract and carried to the liver via the portal
vein, where they may be significantly metabolized before entering the bloodstream.
7. Which protein is the most important for drug binding in the plasma?
A. Hemoglobin
B. Albumin
C. Gamma globulin
D. Transferrin
Answer: B
, Explanation: Albumin is the primary protein to which drugs bind; low albumin levels can
lead to increased levels of free (active) drug.
8. Which route of administration provides 100% bioavailability?
A. Intravenous
B. Intramuscular
C. Oral
D. Transdermal
Answer: A
Explanation: Intravenous administration bypasses absorption barriers and the first-pass
effect, delivering the entire dose directly into systemic circulation.
9. A patient with chronic renal failure would likely require:
A. Lower doses or longer intervals of renal-excreted drugs
B. Higher doses of renal-excreted drugs
C. Frequent administration of prodrugs
D. No change in medication dosing
Answer: A
Explanation: Decreased renal clearance means drugs stay in the body longer, necessitating
dose reductions or increased dosing intervals to avoid toxicity.
